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The effects of brefeldin A on intracellular transport and posttranslational modification of complement C3 
(C3) were studied in primary culture of rat hepatocytes. In the control culture C3 was synthesized as a pre- 
cursor (pro-C3), which was processed to the mature form with a- and /?-subunits before its discharge into 
the medium. In the presence of brefeldin A the secretion of C3 was strongly blocked, resulting in accumu- 
lation of pro-C3. However, after a prolonged interval the mature form of C3 was finally secreted. The results 
indicate that brefeldin A impedes translocation of pro-C3 to the Golgi complex where prcK3 is converted 
to the mature form, but not its proteolytic processing, in contrast to the effects of monensin and weakly 
basic amines. 
Brefeldin A; Secretion-blocking agent; Complement C3; Complement precursor accumulation; (Rat hepatocyte) 
1. INTRODUCTION 
Brefeldin A is a macrolide antibiotic having a 
potent inhibitory activity against virus multiplica- 
tion [ 11. Takatsuki and Tamura [2] have recently 
found that brefeldin A inhibits the cell-surface ex- 
pression of G-protein in vesicular stomatitis virus- 
infected baby hamster kidney cells, resulting in the 
accumulation of G-protein with high-mannose 
type oligosaccharides. The results indicate that in- 
hibition of virion assembly on the cell surface is a 
cause of the antiviral effect of brefeldin A. These 
findings prompted us to elucidate the effects of 
brefeldin A on intracellular transport of secretory 
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proteins as a new perturbant of the secretory 
pathway. In [3], we reported the effects of 
brefeldin A on intracellular transport and con- 
comitant processing of albumin, crl-protease in- 
hibitor and haptoglobin. The results clearly 
demonstrate that the mode of action of brefeldin 
A is different from that of other perturbants such 
as monensin [4-61, antimicrotubular agents [5,7] 
and weakly basic amines [8,9], suggesting that 
brefeldin A is a potent agent for dissecting the in- 
tracellular transport pathway of secretory proteins 
[3] as well as membrane proteins [2]. 
The third component of complement (C3) is syn- 
thesized as a proform (pro-C3, M, 185000) and in- 
tracellularly converted to the cry- (Mr 115 000) and & 
(Mr 65000) subunits before its secretion [lo]. We 
have recently demonstrated that the proteolytic 
conversion of pro-C3 occurs in the Golgi complex 
using an immunoblotting method [l 11. Here, we 
examined the effects of brefeldin A on the pro- 
teolytic processing of pro-C3 in cultured rat 
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hepatocytes to characterize further the effects of 
brefeldin A on the secretory pathway. 
2. MATERIALS AND METHODS 
2.1. Materials 
L-[3sS]Methionine (1200 Ci/mmol) was pur- 
chased from New England Nuclear (Boston, MA), 
cycloheximide from Sigma (St. Louis, MO), 
monensin from Calbiochem-Behring (La Jolla, 
CA), nigericin from Lilly (Indianapolis, IN), 
MEM from Nissui Seiyaku (Tokyo) and goat anti- 
rat C3 antiserum from Cappel (West Chester, PA). 
Brefeldin A was isolated in crystalline form from 
FL-24 fungi, as described [2]. A stock solution was 
made in methanol (5 mg/ml) and stored at - 20°C 
until use. Rat serum C3 was purified from freshly 
prepared rat serum by affinity chromatography 
through an anti-(rat C3)-IgG-Sepharose column 
]121. 
2.2. Hepatocyte culture 
Hepatocytes were isolated from adult male 
Wistar rats, weighing 200-250 g, by the col- 
lagenase perfusion method [ 131. Isolated hepato- 
cytes were cultured at 37°C for 2 days before 
experiments as in [4,5]. 
2.3. Labeling and immunoprecipitation of C3 
Cells were preincubated for 1 h in methionine- 
free MEM in the absence or presence of brefeldin 
A (5 /cg/ml). The cells were then pulse-labeled with 
[35S]methionine (100&i/1.5 ml per dish) for 
15 min and chased in the presence of 100 PM 
cycloheximide. Brefeldin A was present through- 
out experiments. At the indicated times, cell lysates 
and media were prepared and used for immuno- 
precipitation of C3 as in [6,12]. For steady 
labeling, cells were preincubated for 30 min and 
labeled with 25 ,&i [35S]methionine for 2 h in the 
absence or presence of either monensin (5 PM), 
nigericin (5 PM) or methylamine (10 mM), fol- 
lowed by immunoprecipitation of C3 as above. 
2.4. Polyacrylamide gel electrophoresis 
Immunoprecipitates were analyzed by elec- 
trophoresis on 7.5% polyacrylamide gels in the 
presence of SDS, followed by fluorography as 
described in [9,10]. 
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3. RESULTS AND DISCUSSION 
In a previous paper [lo] we have shown that pro- 
C3 is converted to mature C3 with a- and ,&- 
subunits in the Golgi complex before being re- 
leased into the medium. This is based on the 
findings that pro-C3 is not detected in the medium 
and that the proteolytic conversion of pro-C3 is in- 
hibited by monensin, a perturbant of the Golgi 
complex [lo]. However, we failed to demonstrate 
the presence of the CY- and &subunits within the 
cells, suggesting the possibility that pulse-chase x- 
periments did not proceed properly and/or that the 
mature C3, once formed, is quickly exported out 
of the cells. In the present study we carried out the 
chase experiments in the presence of cycloheximide 
so that complete cessation of labeled amino acid 
incorporation into pro-C3 after a pulse period 
could increase the ratio of the newly converted 
mature C3 to the precursor. 
Fig.1 illustrates the effect of brefeldin A on 
secretion of C3. Cells were pulse labeled with 
[35S]methionine for 15 min and chased for various 
times in the absence or presence of brefeldin A 
(5 pg/ml). In the control culture C3 appeared in 
the medium within 30 min after start of the chase. 
This is consistent with previous experiments 
without cycloheximide [lo], indicating that con- 
tinuous protein synthesis is not required for the in- 
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Fig.1. Time course of secretion of complement C3 in a 
primary culture of rat hepatocytes. Hepatocytes were 
pulse-labeled for 15 min with [35S]methionine and 
chased in the absence (0) or presence (0) of brefeldin A 
(5 pg/ml) as described in section 2. At the indicated 
times, immunoprecipitates of C3 were prepared from 
cell lysates and media, and the radioactivity determined. 
Values are expressed as percentages of the radioactivity 
secreted of the total radioactivity incorporated into C3 
during 15 min pulse. 
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tracellular transport of newly synthesized C3. 
However, in the presence of brefeldin A the secre- 
tion of C3 was delayed more than 2 h as compared 
with that in the control culture. 
The proteolytic processing of pro-C3 was 
analyzed by pulse-chase xperiments, followed by 
SDS-polyacrylamide gel electrophoresis (fig.2). In 
the control culture (fig.ZA), the proform which ap- 
peared as a single form just after the pulse labeling 
(lane 1) started to be processed to the mature form 
with LY- and &subunits within 30 min of chase 
(lane 2), indicating that pro-C3 reached its conver- 
sion site by that time. C3 was finally released into 
the medium after being completely converted to 
the mature form, since no proform was detected in 
the medium (lane 6). Most recently we have 
demonstrated the presence of the (Y- and&subunits 
in Golgi fractions but not in rough and smooth 
microsomes isolated from rat liver by means of im- 
munoblotting [l 11. Thus, the appearance of the 
subunits of C3 can be used as a good marker to 
monitor the intracellular transport of C3 from the 
endoplasmic reticulum to the Golgi complex. 
In the presence of brefeldin A, however, the ap- 
pearance of the subunits of C3 was markedly 
delayed (fig.ZB). Only the proform was present in 
cells up to 2 h of chase (lanes l-4), after which the 
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Fig.2. Effect of brefeldin A on intr&ellular processing 
of complement C3. Cells were pulse-labeled and chased 
in the absence (A) or presence (B) of brefeldin A 
(5 pg/ml) as shown in fig.l. Immunoprecipitates of C3 
were prepared from cell lysates (lanes 1-5) and media 
(lane 6), and analyzed by SDS-polyacrylamide gel 
electrophoresis followed by fluorography. Lanes: 1, no 
chase; 2, chase 30 min; 3, 1 h; 4,2 h; 5,6, 3 h. P, (Y and 
fl denote the proform, (Y- and&subunits, respectively, of 
c3. 
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Fig.3. Effects of perturbants of the Golgi complex on 
the proteolytic processing of complement C3. Cells were 
labeled for 2 h with [“Slmethionine in the absence or 
presence of the following drugs as described in section 2. 
Immunoprecipitates prepared from cell lysates (lanes 
1,3,5,7) and media (lanes 2,4,6,8) were analyzed by SDS- 
polyacrylamide gel electrophoresis followed by 
fluorography. Lanes: 1,2, no drug; 3,4, monensin 
(5 /cM); 5,6, nigericin (5 ,uM); 7.8, methylamine 
(10 mM). P , a and g denote the proform, (Y- and fi- 
subunits, respectively, of C3. 
processed form was detectable in the cells (lane 5) 
and secreted into the medium (lane 6), coincident 
with the time course of secretion (fig.1). The 
delayed secretion was accompanied by a mor- 
phological alteration with marked dilation of the 
endoplasmic reticulum as shown in [3]. The 
finding that no proform was detectable in the 
medium as in the control culture (lane 6 in 
fig.ZA,B) suggests that the drug causes no signifi- 
cant inhibition of proteolytic cleavage of pro-C3. 
Taken together, these results indicate that 
brefeldin A primarily impedes intracellular 
transport of the proform to its conversion site, the 
Golgi complex, resulting in delayed secretion of 
the mature form after prolonged accumulation of 
the proform in cells. This effect is different from 
those of other secretion-blocking agents such as 
carboxylic ionophores and weakly basic amines, 
which commonly cause not only swelling of the 
Golgi elements, but also dysfunctions of the Golgi 
complex [4,5,8-lo]. In fact, when the cells were 
treated with these drugs, a considerable amount of 
pro-C3 was released directly into the medium, as 
typified in fig.3 for monensin (lane 4), nigericin 
(lane 6) and methylamine (lane 8). 
The present study and the previous one [3] 
demonstrate that brefeldin A markedly retards the 
137 
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translocation of pro-C3 and proalbumin to the site 
where proteolytic cleavage of both precursors 
takes place. The most proximal site for proteolytic 
conversion of both precursors is supposed to be an 
acidic truns region of the Golgi complex, since 
acidotropic agents including carboxylic ionophores 
and weakly basic amines disturb this particular 
processing occurring in the Golgi complex [8,9,14]. 
Thus, we cannot exclude the possibility that 
brefeldin A affects the intra-Golgi transport from 
cis to trans Golgi subcompartments other than 
translocation from the endoplasmic reticulum to 
the Golgi complex. Analysis of processing of 
asparagine-linked oligosaccharides in the presence 
of brefeldin A should provide a clue for specifying 
the target site of this novel perturbant of the ex- 
ocytotic pathway. 
ACKNOWLEDGEMENT 
This work was supported in part by a Grant-in- 
Aid for Scientific Research from the Ministry of 
Education, Science and Culture of Japan. 
REFERENCES 
111 
PI 
131 
141 
PI 
161 
171 
WI 
191 
1101 
[III 
1121 
1131 
1141 
Tamura, G., Ando, K., Takatsuki, A. and Arima, 
K. (1968) J. Antibiot. 21, 160-161. 
Takatsuki, A. and Tamura, G. (1985) Agric. Biol. 
Chem. 49, 899-902. 
Misumi, Y., Misumi, Y., Miki, K., Takatsuki, A., 
Tamura, G. and Ikehara,‘Y. (1986) J. Biol. Chem. 
261, 11398-11403. 
Oda, K. and Ikehara, Y. (1982) Biochem. Biophys. 
Res. Commun. 105, 766-772. 
Oda, K., Misumi, Y. and Ikehara, Y. (1983) Eur. 
J. Biochem. 135, 209-216. 
Misumi, Y., Tanaka, Y. and Ikehara, Y. (1983) 
Biochem. Biophys. Res. Commun. 114, 729-736. 
Oda, K. and Ikehara, Y. (1982) Biochem. Biophys. 
Res. Commun. 107, 561-567. 
Oda, K. and Ikehara, Y. (1985) Eur. J. Biochem. 
152, 605-609. 
Oda, K., Koriyama, Y.. Yamada, E. and Ikehara, 
Y. (1986) Biochem. J. 240, 739-745. 
Misumi, Y., Takami, N. and Ikehara, Y. (1983) 
FEBS Lett. 175, 63-67. 
Oda, K., Miki, K., Hirose, S., Takami, N., 
Misumi, Y. and Ikehara, Y. (1986) J. Biochem. 
100, 1669-1675. 
Miki, K., Ogata, S., Misumi, Y. and Ikehara, Y. 
(1986) Biochem. J. 240, 691-698. 
Seglen, P.O. (1975) Methods Cell Biol. 13, 29-83. 
Hortin, G. and Strauss, A.W. (1986) Biochem. Bio- 
phys. Res. Commun. 136, 603-609. 
138 
